188 related articles for article (PubMed ID: 26312152)
1. Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis.
Ostendorf T; Boor P; van Roeyen CR; Floege J
Kidney Int Suppl (2011); 2014 Nov; 4(1):65-69. PubMed ID: 26312152
[TBL] [Abstract][Full Text] [Related]
2. The PDGF family in renal fibrosis.
Ostendorf T; Eitner F; Floege J
Pediatr Nephrol; 2012 Jul; 27(7):1041-50. PubMed ID: 21597969
[TBL] [Abstract][Full Text] [Related]
3. A new look at platelet-derived growth factor in renal disease.
Floege J; Eitner F; Alpers CE
J Am Soc Nephrol; 2008 Jan; 19(1):12-23. PubMed ID: 18077793
[TBL] [Abstract][Full Text] [Related]
4. The platelet-derived growth factor system in renal disease: an emerging role of endogenous inhibitors.
van Roeyen CR; Ostendorf T; Floege J
Eur J Cell Biol; 2012; 91(6-7):542-51. PubMed ID: 21872965
[TBL] [Abstract][Full Text] [Related]
5. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
6. PDGF and the progression of renal disease.
Boor P; Ostendorf T; Floege J
Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i45-i54. PubMed ID: 24493869
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats.
Kliem V; Johnson RJ; Alpers CE; Yoshimura A; Couser WG; Koch KM; Floege J
Kidney Int; 1996 Mar; 49(3):666-78. PubMed ID: 8648907
[TBL] [Abstract][Full Text] [Related]
8. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
9. The role of PDGF-D in healthy and fibrotic kidneys.
Buhl EM; Djudjaj S; Babickova J; Klinkhammer BM; Folestad E; Borkham-Kamphorst E; Weiskirchen R; Hudkins K; Alpers CE; Eriksson U; Floege J; Boor P
Kidney Int; 2016 Apr; 89(4):848-61. PubMed ID: 26924050
[TBL] [Abstract][Full Text] [Related]
10. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
11. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury.
Taneda S; Hudkins KL; Topouzis S; Gilbertson DG; Ophascharoensuk V; Truong L; Johnson RJ; Alpers CE
J Am Soc Nephrol; 2003 Oct; 14(10):2544-55. PubMed ID: 14514732
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.
Tang WW; Ulich TR; Lacey DL; Hill DC; Qi M; Kaufman SA; Van GY; Tarpley JE; Yee JS
Am J Pathol; 1996 Apr; 148(4):1169-80. PubMed ID: 8644858
[TBL] [Abstract][Full Text] [Related]
13. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
Roskoski R
Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
15. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
López-Hernández FJ; López-Novoa JM
Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
[TBL] [Abstract][Full Text] [Related]
16. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis.
Niemir ZI; Stein H; Noronha IL; Krüger C; Andrassy K; Ritz E; Waldherr R
Kidney Int; 1995 Nov; 48(5):1530-41. PubMed ID: 8544410
[TBL] [Abstract][Full Text] [Related]
17. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
18. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
Floege J; Eng E; Young BA; Alpers CE; Barrett TB; Bowen-Pope DF; Johnson RJ
J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
[TBL] [Abstract][Full Text] [Related]
19. C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis.
Wilkening A; Krappe J; Mühe AM; Lindenmeyer MT; Eltrich N; Luckow B; Vielhauer V
Nephrol Dial Transplant; 2020 Feb; 35(2):227-239. PubMed ID: 30597038
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats.
Nakagawa H; Sasahara M; Haneda M; Koya D; Hazama F; Kikkawa R
Diabetes Res Clin Pract; 2000 May; 48(2):87-98. PubMed ID: 10802145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
